RPRX
Repros Therapeutics Inc.
RPRX
RPRX
Delisted
RPRX was delisted on the 31st of January, 2018.
64 hedge funds and large institutions have $106M invested in Repros Therapeutics Inc. in 2015 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 16 increasing their positions, 21 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
24% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 21
32% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 25
Holders
64
Holding in Top 10
1
Calls
$3.18M
Puts
$2.96M
Top Buyers
1 | +$3.55M | |
2 | +$1.45M | |
3 | +$1.12M | |
4 |
Morgan Stanley
New York
|
+$1.05M |
5 |
Millennium Management
New York
|
+$712K |
Top Sellers
1 | -$4.51M | |
2 | -$3.29M | |
3 | -$2.42M | |
4 |
SAM
Senzar Asset Management
New York
|
-$2.1M |
5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$1.72M |